Related Experiment Video
Updated: May 15, 2025

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness
Published on: December 6, 2024
Large Language Models and Their Applications in Drug Discovery and Development: A Primer
James Lu1, Keunwoo Choi2, Maksim Eremeev2
1Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
Large language models (LLMs) offer powerful applications in clinical pharmacology and translational medicine, enhancing drug discovery, development, and research workflows for scientists.
Area of Science:
- Pharmacology
- Translational Medicine
- Artificial Intelligence
Background:
- Large language models (LLMs) are increasingly influential across scientific domains.
- Their potential in specialized fields like clinical pharmacology and translational medicine is significant but requires focused exploration.
- Understanding LLM capabilities is crucial for advancing drug discovery and development.
Purpose of the Study:
- To provide a comprehensive primer on the applications of LLMs in clinical pharmacology and translational medicine.
- To elucidate the fundamental concepts underpinning LLMs relevant to these scientific disciplines.
- To guide researchers on leveraging LLMs for enhanced research and development efforts.
Main Methods:
- Exploration of LLM fundamental concepts.
- Review of potential applications across the drug discovery and development pipeline.
- Identification of practical use cases in medical writing and quantitative analysis.
Main Results:
- LLMs can facilitate target identification and aid preclinical research.
- LLMs assist in clinical trial analysis and quantitative clinical pharmacology workflows.
- LLMs support medical writing tasks, accelerating analytical processes.
Conclusions:
- LLMs present transformative potential for clinical pharmacology and translational medicine.
- Researchers can utilize LLMs to optimize various stages of drug discovery and development.
- A clear understanding of LLMs empowers scientists to enhance their R&D endeavors.
Related Concept Videos
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

